GM Watch
  • Main Menu
    • Home
    • News
      • Latest News
      • Newsletter subscription
      • Daily Digest
      • News Reviews
      • News Languages
    • Articles
      • GM Myth Makers
      • GM Reports
      • GM Quotes
      • GM Myths
      • Non-GM successes
      • GM Firms
        • Monsanto: a history
        • Monsanto: resources
        • Bayer: a history
        • Bayer: resources
    • Videos
      • Latest Videos
      • Must see videos
      • Cornell videos
      • Agriculture videos
      • Labeling videos
      • Animals videos
      • Corporations videos
      • Corporate takeover videos
      • Contamination videos
      • Latin America videos
      • India videos
      • Asia videos
      • Food safety videos
      • Songs videos
      • Protests videos
      • Biofuel myths videos
      • Index of GM crops and foods
      • Index of speakers
    • Contact
    • About
    • Links
    • Donations
    • How donations will help us
News and comment on genetically modified foods and their associated pesticides    
  • News
    • Latest News
    • Newsletter subscription
    • Archive
      • 2018 articles
      • 2015 articles
      • 2017 articles
      • 2016 articles
      • 2014 articles
      • 2013 articles
      • 2012 articles
      • 2011 articles
      • 2010 articles
      • 2009 articles
      • 2008 articles
      • 2007 articles
      • 2006 articles
      • 2005 articles
      • 2004 articles
      • 2003 articles
      • 2002 articles
      • 2001 articles
      • 2000 articles
    • Daily Digest
    • News Reviews
    • News Languages
      • Notícias em Português
      • Nieuws in het Nederlands
      • Nachrichten in Deutsch
  • Articles
    • GM Myth Makers
    • GM Reports
    • How donations will help us
    • GM Quotes
    • GM Myths
    • Non-GM successes
    • GM Firms
      • Monsanto: a history
      • Monsanto: resources
      • Bayer: a history
      • Bayer: resources
  • Videos
    • Latest Videos
    • Must see videos
    • Cornell videos
    • Agriculture videos
    • Labeling videos
    • Animals videos
    • Corporations videos
    • Corporate takeover videos
    • Contamination videos
    • Latin America videos
    • India videos
    • Asia videos
    • Food safety videos
    • Songs videos
    • Protests videos
    • Biofuel myths videos
    • Index of GM crops and foods
    • Index of speakers
    • Glyphosate Videos
  • Contact
  • About
  • Links
  • Donations
SUBSCRIBE TO REVIEWS

GMO INFO

10 Questions About GM Foods
Do GMOs increase yields and reduce pesticide use, and are they needed to feed the world? Find out in the 16-page document, 10 Questions About GM Foods.

News Menu

  • Latest News
  • News Reviews
  • Archive
  • Languages

News Archive

  • 2018 articles
  • 2017 articles
  • 2016 articles
  • 2015 articles
  • 2014 articles
  • 2013 articles
  • 2012 articles
  • 2011 articles
  • 2010 articles
  • 2009 articles
  • 2008 articles
  • 2007 articles
  • 2006 articles
  • 2005 articles
  • 2004 articles
  • 2003 articles
  • 2002 articles
  • 2001 articles
  • 2000 articles

Please support GMWatch

Donations

You can donate via Paypal or credit/debit card.

Some of you have opted to give a regular donation. This is greatly appreciated as it helps place us on a more stable financial basis. Thank you for your support!

2005 articles

Biotech Company Closes After Running Out of Cash

  • Print
  • Email
Details
Published: 23 December 2005
Created: 23 December 2005
Last Updated: 22 October 2012
Twitter

EXCERPT: Robert L. Erwin, a founder and the chairman of Large Scale, said the bigger problem for his company was the reluctance of drug companies to have their products developed in crops... "There are very few corporate executives willing to bet on an unproven process."

Moreover, he said, pharmaceutical crop developers are wrong in assuming that lower production costs are an important consideration for drug companies.

With high prices for their drugs, Mr. Erwin said, "cost is not really an issue for them."
---

Biotech Company Closes After Running Out of Cash
By ANDREW POLLACK
New York Times, Dec 24 2005
http://www.theledger.com/apps/pbcs.dll/article?AID=/20051224/ZNYT01/512240414/1001/BUSINESS

In a setback for a controversial area of biotechnology, the company that led the way in trying to produce pharmaceuticals in genetically modified crops ran out of money and shut its doors yesterday.

The company, the Large Scale Biology Corporation, based in Vacaville, Calif., said in a statement Thursday that all of its approximately 70 employees had been let go.

Large Scale was founded in 1987 as Biosource Genetics and was apparently the first company to try to produce protein-based drugs and industrial chemicals in genetically engineered plants.

Such production, it argued, would be faster and far less expensive than using genetically engineered bacteria or animal cells, which is the usual method of producing pharmaceutical proteins like insulin and growth hormone.

But environmental groups and food companies have expressed opposition to pharmaceutical-producing crops, saying that drugs might accidentally end up in the food supply, causing health problems and forcing costly product recalls.

Large Scale used tobacco, a nonfood crop, so its technology was somewhat less controversial than that of companies using corn or rice. And under the method used by the company, the genes put into the tobacco plant could not be spread by pollen.

Still, controversy over agricultural biotechnology in general has made it difficult for small companies in that business to raise money.

Robert L. Erwin, a founder and the chairman of Large Scale, said the bigger problem for his company was the reluctance of drug companies to have their products developed in crops.

Since there are no crop-produced pharmaceuticals on the market yet, he said, drug companies do not know how easy it will be to win approval for such drugs from the Food and Drug Administration.

"Everybody wants to be the second one out," Mr. Erwin said. "There are very few corporate executives willing to bet on an unproven process."

Moreover, he said, pharmaceutical crop developers are wrong in assuming that lower production costs are an important consideration for drug companies.

With high prices for their drugs, Mr. Erwin said, "cost is not really an issue for them."

Large Scale's demise is a blow to Owensboro, Ky., in the heart of tobacco country, where Large Scale has a factory to extract drugs from the tobacco.

Some civic leaders in Owensboro had been hoping that pharmaceutical production would be a source of income for tobacco farmers and the basis for a local biotechnology industry.

A recent study by Robert Wisner, a professor of economics at Iowa State University, said that benefits to farmers and rural economies from pharmaceutical crops were likely to be modest. The report was sponsored by the Union of Concerned Scientists, which is critical of agricultural biotechnology.

Large Scale was selling one tobacco-produced protein for use by research laboratories and industry. It was working on producing enzymes to treat rare diseases, a cancer treatment and vaccines.

In the company's statement, the chief executive, Kevin J. Ryan, said that Large Scale was "taking steps to preserve our assets for the benefit of our creditors and stockholders."

The company said it was still in talks with potential collaborators on deals that could raise money and is also talking with potential acquirers.

The company went public at $17 a share in 2000, the year of a biotech investing frenzy in which dozens of companies issued stock.

Even after a recent reverse split aimed at building up the price per share by reducing the number of shares, the stock closed at 19 cents on Friday. That will be its last day of trading on a Nasdaq market because the company said it would not appeal a decision by Nasdaq to delist it.

  • Prev
  • Next

Menu

Home

News

News Archive

News Reviews

Videos

Articles

GM Myth Makers

GM Reports

GM Myths

GM Quotes

How Donations Will Help Us

Contacts

Contact Us

About

Facebook

Twitter

RSS

Content 1999 - 2018 GMWatch.
Web Development By SCS Web Design